New Michigan Poll Finds Broad Bipartisan Support for Greater Hospital Accountability and 340B Transparency
WASHINGTON — A new survey of Michigan voters conducted by Echelon Insights on behalf of the American Resolve Action’s Hospital […]
WASHINGTON — A new survey of Michigan voters conducted by Echelon Insights on behalf of the American Resolve Action’s Hospital […]
WASHINGTON — A new survey of Georgia voters conducted by Echelon Insights on behalf of the American Resolve Action’s Hospital
FOX Business’ Gerri Willis reports on health care abuse accusations against the federal 340B drug program and the impact of costs on ‘Varney & Co.’
WASHINGTON (May 8, 2026) — The Hospital Accountability Project convened a roundtable of leading health policy experts this week to
WASHINGTON — A new survey of Idaho voters conducted by Echelon Insights on behalf of the American Resolve Action’s Hospital
WASHINGTON — A new survey of Utah voters conducted by Echelon Insights on behalf of the American Resolve Action’s Hospital
A federal judge shows how this hospital ‘discount’ fleeces drug makers and patients.
President Trump and his administration are pushing ahead with a reform that could prevent billions of dollars in annual waste, fraud, and abuse. And it could start saving taxpayers money as soon as January — progress, by Washington standards — as long as congressional Republicans don’t undermine him.
President Trump and his administration are pushing ahead with a reform that could prevent billions of dollars in annual waste, fraud, and abuse. And it could start saving taxpayers money as soon as January — progress, by Washington standards — as long as congressional Republicans don’t undermine him.
President Donald Trump has repeatedly vowed to “cut waste, fraud and abuse everywhere that we can find it.” Congressional Republicans now have an opportunity to help him achieve that goal by supporting the administration’s efforts to stop hospitals from abusing a little-known federal charity care program.
A drug discount program has fueled consolidation and incentivized prescribing more expensive medications.